OneMedNet (NASDAQ:ONMD) CEO Aaron Green Sells 1,667 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 1,667 shares of the stock in a transaction on Thursday, September 24th. The stock was sold at an average price of $6.48, for a total value of $10,802.16. Following the completion of the sale, the chief executive officer owned 247,971 shares in the company, valued at $1,606,852.08. This trade represents a 0.67% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Aaron Green also recently made the following trade(s):

• On Tuesday, September 22nd, Aaron Green sold 5,000 shares of OneMedNet stock. The stock was sold at an average price of $7.39, for a total value of $36,950.00.

OneMedNet Stock Down 10.8%

Shares of NASDAQ ONMD opened at $4.30 on Friday. The firm has a market capitalization of $25.50 million, a P/E ratio of -2.69 and a beta of 1.14. The stock’s 50-day simple moving average is $6.24 and its two-hundred day simple moving average is $7.32. OneMedNet Corporation has a twelve month low of $4.30 and a twelve month high of $42.20.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company presently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.